HIV-1 Associated Dementia: Clinical Features and Pathogenesis

Keyphrases

• Clinical Features 100%
• HIV-associated Dementia 100%
• Nitric Oxide 20%
• Poor Prognosis 20%
• Neurotoxicity 20%
• Neuroimaging 20%
• Gp120 20%
• Age of Infection 20%
• Multiple Mechanisms 20%
• Functional Impairment 20%
• Systemic Disease 20%
• Neurological Injury 20%
• Behavioral Abnormalities 20%
• Motor Dysfunction 20%
• Neuropsychological Tests 20%
• AIDS Patients 20%
• Neurological Syndrome 20%
• HIV-1 Infection 20%
• In Vitro Assay 20%
• Rational Development 20%
• Blood-brain Barrier Permeability 20%
• Arachidonic Acid Cascade 20%
• Opportunistic Diseases 20%
• Subcortical Dementia 20%
• Clinical Triad 20%
• Quinolinic Acid 20%
• CNS Injury 20%
• Neurovirulent 20%
• Collective Approach 20%
• Longitudinal Cognitive Decline 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Feature 100%
• HIV Associated Dementia 100%
• Pathogenesis 100%
• HIV 40%
• Acquired Immune Deficiency Syndrome 40%
• Diseases 40%
• Nitric Oxide 20%
• Infection 20%
• Neurotoxicity 20%
• Cytokine 20%
• Human Immunodeficiency Virus 1 Infection 20%
• Neurologic Disease 20%
• Clinical Study 20%
• Functional Disease 20%
• Motor Dysfunction 20%
• Arachidonic Acid 20%
• Systemic Disease 20%
• Quinolinic Acid 20%
• Blood-Brain Barrier 20%
• Disability 20%

Neuroscience

• HIV Associated Dementia 100%
• Human Immunodeficiency Virus 60%
• Nitric Oxide 20%
• In Vitro 20%
• Blood Brain Barrier 20%
• Neurotoxicity 20%
• Stereotypic Movement Disorder 20%
• Arachidonic Acid 20%
• Quinolinic Acid 20%
• Cytokine 20%
• Psychopathology 20%
• Cognitive Decline 20%